Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

This study has been terminated.

( closed by sponser )

Study NCT00034372 Information provided by Unither Pharmaceuticals

First Received: April 26, 2002 Last Updated: December 13, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	December 2007
Estimated Primary Completion Date:	No date given